New Novae: Termination of Issuance of Shares and Payment of Cash to Purchase Assets

In the latest announcement, the company was originally planning to acquire 100% equity of Shiyao Baike through issuing shares and paying cash, while also planning to issue shares to raise funds from up to 35 specific investors. Since the company planned and first announced the transaction, the company has strictly complied with relevant laws, regulations, and normative documents, actively organizing all parties involved in the transaction to promote the restructuring work. However, considering that the time elapsed since the planning of this restructuring matter has been quite long, and that there have been certain changes in the pharmaceutical industry and the overall capital market environment since the beginning of the restructuring planning, in order to safeguard the long-term interests of all shareholders of the company, after friendly negotiations, careful study, and thorough argumentation between the company and all parties involved in the transaction, based on cautious consideration, it has been decided to terminate the restructuring matter.